Interaction of Papillomavirus E6 Oncoproteins with a Putative Calcium-Binding Protein
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Human papillomaviruses (HPVs) are associated with the majority of cervical cancers and encode a transforming protein, E6, that interacts with the tumor suppressor protein p53. Because E6 has p53-independent transforming activity, the yeast two-hybrid system was used to search for other E6-binding proteins. One such protein, E6BP, interacted with cancer-associated HPV E6 and with bovine papillomavirus type 1 (BPV-1) E6. The transforming activity of BPV-1 E6 mutants correlated with their E6BP-binding ability. E6BP is identical to a putative calcium-binding protein, ERC-55, that appears to be localized in the endoplasmic reticulum.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and may be responsible for the different cell type-specific tropisms of the two genera”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [67]
In the citing paper
“Both virus–host interactions are mediated by a similar motif in the cellular protein”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [67]
In the citing paper
“the E6 protein of genus alpha HPV binds specifically to the cellular E6AP protein”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [67]
In the citing paper
“while that of the genus beta HPV binds specifically to cellular MAML1.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [67]
Citations
Cites
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,114
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Chien, C. T., Bartel, P. L., Sternglanz, R., & Fields, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9578 · Cited by 1,492
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
A novel genetic system to detect protein-protein interactions
Chien, C. (1991) · Proceedings of the National Academy of Sciences · Cited by 532
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., & Cho, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3988 · Cited by 526
Crook, T., Vousden, K. H., & Tidy, J. A. (1991) · Cell · doi:10.1016/0092-8674(91)90529-8 · Cited by 505
Research works printed but not linked: 1
- MANSUR, C.P., CELLULAR-TRANSFORMATION BY PAPILLOMAVIRUS ONCOPROTEINS, BIOCHIMICA ET BIOPHYSICA ACTA 1155: 323 (1993).
Cited by
Items 101–200 of 302
Interaction of oncogenic papillomavirus E6 proteins with fibulin-1
Du, M., Fan, X., Hong, E., & Chen, J. J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02041-7 · Cited by 67
Self-citationTelomerase activation in cervical cancer.
Anderson, S., Shera, K. A., Ihle, J., Billman, L., Goff, B. A., Greer, B. E., Tamimi, H. K., McDougall, J. K., & Klingelhutz, A. J. (1997) · Europe PMC (PubMed Central) · Cited by 67
Habbous, S., Pang, V., Eng, L., Xu, W., Kurtz, G. A., Liu, F., Mackay, H., Amir, E., & Liu, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1983 · Cited by 66
PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein
Gao, Q., Kumar, A., Srinivasan, S., Singh, L., Mukai, H., Ono, Y., Wazer, D. E., & Band, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14824 · Cited by 61
Self-citationMolecular Mechanism of Carcinogenesis by Human Papillomavirus‐16
Ishiji, T. (2000) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2000.tb02126.x · Cited by 66
Cell cycle regulation in the developing lens
Griep, A. E. (2006) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2006.10.004 · Cited by 65
Nguyen, M. L., Song, S., Liem, A., Androphy, E. J., Liu, Y., & Lambert, P. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13039-13048.2002 · Cited by 65
Self-citationGps2, a Protein Partner for Human Papillomavirus E6 Proteins
Degenhardt, Y. Y., & Silverstein, S. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.151-160.2001 · Cited by 58
Human Papilloma Virus (HPV) and Host Cellular Interactions
Mammas, I., Sourvinos, G., Giannoudis, A., & Spandidos, D. A. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9056-6 · Cited by 60
Inactivation of the human papillomavirus-16 e6 oncoprotein by organic disulfides
Beerheide, W., Sim, M. M., Tan, Y., Bernard, H., & Ting, A. E. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00193-0 · Cited by 60
Nuclear Entry of High-Risk Human Papillomavirus Type 16 E6 Oncoprotein Occurs via Several Pathways
Roux, L. L., & Moroianu, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2330-2337.2003 · Cited by 59
Be, X., Hong, Y., Wei, J., Androphy, E. J., Chen, J. J., & Baleja, J. D. (2001) · Biochemistry · doi:10.1021/bi0019592 · Cited by 51
Self-citationProteomic approaches to the study of papillomavirus-host interactions
White, E. A., & Howley, P. M. (2013) · Virology · doi:10.1016/j.virol.2012.09.046 · Cited by 57
Yuan, Z., Gault, E. A., Gobeil, P., Nixon, C., Campo, M. S., & Nasir, L. (2008) · Virology · doi:10.1016/j.virol.2007.11.037 · Cited by 57
Magal, S. S., Jackman, A., Ish-Shalom, S., Edry‐Botzer, L., Gonen, P., Schlegel, R., & Sherman, L. (2005) · Journal of General Virology · doi:10.1099/vir.0.80453-0 · Cited by 57
Gagnon, S., Hankins, C. A., Tremblay, C. L., Forest, P., Pourreaux, K., Coutlée, F., & Canadian Women’s HIV Study Group (2004) · The Journal of Infectious Diseases · doi:10.1086/424854 · Cited by 56
Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins
Grace, M. R., & Münger, K. (2016) · Virology · doi:10.1016/j.virol.2016.10.010 · Cited by 55
Transactivation of Prothymosin α and c-mycPromoters by Human Papillomavirus Type 16 E6 Protein
Kinoshita, T., Shirasawa, H., Shino, Y., Moriya, H., Desbarats, L., Eilers, M., & Simizu, B. (1997) · Virology · doi:10.1006/viro.1997.8536 · Cited by 54
Bovine Papillomavirus E7 Oncoprotein Inhibits Anoikis
DeMasi, J., Chao, M. C., Kumar, A. S., & Howley, P. M. (2007) · Journal of Virology · doi:10.1128/jvi.00422-07 · Cited by 43
Papillomaviruses and Cervical Cancer: Pathogenesis and Vaccine Development
Lowy, D. R., & Schiller, J. T. (1998) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024169 · Cited by 53
Calumenin interacts with serum amyloid P component
Vorum, H., Jacobsen, C. B., & Honoré, B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01734-2 · Cited by 52
Molecular Targets for Human Papillomaviruses: Prospects for Antiviral Therapy
Phelps, W. R., Barnes, J., & Lobe, D. C. (1998) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029800900501 · Cited by 52
Østergaard, M., Hansen, G. A. W., Vorum, H., & Honoré, B. (2006) · PROTEOMICS · doi:10.1002/pmic.200500686 · Cited by 51
The interaction between p53 and papillomaviruses
Mantovani, F., & Banks, L. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0142 · Cited by 51
Kehmeier, E. S., Rühl, H., Voland, B., Stoppler, M. C., Androphy, E. J., & Stöppler, H. (2002) · Virology · doi:10.1006/viro.2002.1502 · Cited by 50
Self-citationGiovane, C., Travé, G., Briones, A., Lutz, Y., Wasylyk, B., & Weiss, É. (1999) · Journal of Molecular Recognition · doi:10.1002/(sici)1099-1352(199903/04)12:2<141::aid-jmr453>3.0.co;2-o · Cited by 50
Guccione, E., Massimi, P., Bernat, A., & Banks, L. (2002) · Virology · doi:10.1006/viro.2001.1290 · Cited by 49
Bohl, J., Das, K., Dasgupta, B., & Pol, S. V. (2000) · Virology · doi:10.1006/viro.2000.0316 · Cited by 49
Yim, E.-K., & Park, J. S. (2006) · Biomarker Insights · doi:10.1177/117727190600100015 · Cited by 48
Ratsch, S. B., Gao, Q., Srinivasan, S., Wazer, D. E., & Band, V. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0143:mgcarf]2.0.co;2 · Cited by 44
Self-citationKong, L., Yu, X., Bai, X.-H., Zhang, W., Zhang, Y., Zhao, W., Jia, J., Tang, W., Zhou, Y., & Liu, C.-J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702195200 · Cited by 47
Mohrig, J. R., Rosenberg, R. E., Apostol, J. W., Bastienaansen, M., Evans, J. W., Franklin, S. J., Frisbie, C. D., Fu, S. S., Hamm, M. L., Hirose, C. B., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja962631s · Cited by 47
Nakayama, S., Kawasaki, H., & Kretsinger, R. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-58306-3_2 · Cited by 46
Binding of Human Papillomavirus Type 16 E6 to E6AP Is Not Required for Activation of hTERT
Šekaric, P., Cherry, J. J., & Androphy, E. J. (2007) · Journal of Virology · doi:10.1128/jvi.01776-07 · Cited by 45
Self-citationPrediction of Intrinsic Disorder in Proteins Using MFDp2
Mizianty, M. J., Uversky, V. N., & Kurgan, L. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0366-5_11 · Cited by 44
Hoppe‐Seyler, F., & Butz, K. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00195138 · Cited by 43
Qiao, L., Zheng, J., Tian, Y., Zhang, Q., Wang, X., Chen, J. J., & Zhang, W. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0584-z · Cited by 42
Self-citationHPV 16 E6 Blocks TNF-Mediated Apoptosis in Mouse Fibroblast LM Cells
Duerksen-Hughes, P. J., Yang, J. J., & Schwartz, S. B. (1999) · Virology · doi:10.1006/viro.1999.9977 · Cited by 42
Tungteakkhun, S. S., Filippova, M., Neidigh, J. W., Fodor, N., & Duerksen-Hughes, P. J. (2008) · Journal of Virology · doi:10.1128/jvi.00538-08 · Cited by 41
The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation
Shimada, M., Yamashita, A., Saito, M., Ichino, M., Kinjo, T., Mizuki, N., Klinman, D. M., & Okuda, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-71134-3 · Cited by 40
Das, K., Bohl, J., & Vande Pol, S. B. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.812-816.2000 · Cited by 36
Hansen, G. A. W., Vorum, H., Jacobsen, C. B., & Honoré, B. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9895-1 · Cited by 40
Imai, T., Matsuda, K., Shimojima, T., Hashimoto, T., Masuhiro, Y., Kitamoto, T., Sugita, A., Suzuki, K., Matsumoto, H., Masushige, S., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6531 · Cited by 40
Sherman, L., Itzhaki, H., Jackman, A., Chen, J. J., Koval, D., & Schlegel, R. (2002) · Virology · doi:10.1006/viro.2001.1263 · Cited by 39
Self-citationWei, Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502974200 · Cited by 39
HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers
Manzo-Merino, J., Thomas, M., Fuentes-González, A. M., Lizano, M., & Banks, L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.832204 · Cited by 37
Viral Hijacking of Cellular Ubiquitination Pathways as an Anti-Innate Immunity Strategy
Chen, M., & Gerlier, D. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.349 · Cited by 37
Spangle, J. M., Ghosh-Choudhury, N., & Munger, K. (2012) · Journal of Virology · doi:10.1128/jvi.00487-12 · Cited by 34
Nakakido, M., Tamura, K., Chung, S., Ueda, K., Fujii, R., Kiyotani, K., & Nakamura, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3607 · Cited by 37
THE GENETIC PROGRAM OF GENITAL HUMAN PAPILLOMAVIRUSES IN INFECTION AND CANCER
Turek, L. P., & Smith, E. (1996) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70275-8 · Cited by 37
Gardiol, D., Galizzi, S., & Banks, L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-2-283 · Cited by 36
Structure and function of the papillomavirus E6 protein and its interacting proteins
Liu, Y., & Baleja, J. (2007) · Frontiers in bioscience · doi:10.2741/2664 · Cited by 36
Nguyen, M. M., Potter, S. J., & Griep, A. E. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00644-x · Cited by 36
Gagnon, S., Hankins, C. A., Tremblay, C. L., Pourreaux, K., Forest, P., Rouah, F., & Coutlée, F. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20259 · Cited by 35
Daniels, P. R., Maitland, N. J., & Sanders, C. M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-3-489 · Cited by 35
Human papillomavirus infection, cancer & therapy.
Grm, H. Š., Bergant, M., & Banks, L. (2009) · PubMed · Cited by 34
Filippova, M., Brown‐Bryan, T. A., Casiano, C. A., & Duerksen-Hughes, P. J. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401678 · Cited by 33
The Differentiation-Dependent Life Cycle of Human Papillomaviruses in Keratinocytes
Lee, C., & Laimins, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-36523-7_4 · Cited by 33
HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium
Pei, X. F., Sherman, L., Sun, Y. H., & Schlegel, R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.8.1481 · Cited by 33
Fukuda, T., Oyamada, H., Isshiki, T., Maeda, M., Kusakabe, T., Hozumi, A., Yamaguchi, T., IGARASHI, T., Hasegawa, H., Seidoh, T., et al. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a6943.2006 · Cited by 32
DNA Supercoiling Factor Localizes to Puffs on Polytene Chromosomes in Drosophila melanogaster
Kobayashi, M., Aita, N., Hayashi, S., Okada, K., Ohta, T., & Hirose, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6737 · Cited by 30
Disordered Interactome of Human Papillomavirus
Xue, B., Ganti, K., Rabionet, A., Banks, L., & Uversky, V. N. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990072 · Cited by 29
Harry, J. B., & Wettstein, F. O. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3355-3362.1996 · Cited by 29
Aho, J., Hankins, C. A., Tremblay, C. L., Lang, B. F., Forest, P., Pourreaux, K., Rouah, F., Coutlée, F., & the Canadian Women’s HIV Study Group (2003) · The Journal of Infectious Diseases · doi:10.1086/379198 · Cited by 27
Amirheidari, B., Thirlway, J., & Micklefield, J. (2007) · Organic Letters · doi:10.1021/ol0701619 · Cited by 27
Dakoji, S., Li, D., Agnihotri, G., Zhou, H., & Liu, H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja011226k · Cited by 27
Carraresi, L., Tripodi, S. A., Mulder, L. C. F., Bertini, S., Nuti, S., Schuerfeld, K., Cintorino, M., Bensi, G., Rossini, M., & Mora, M. (2001) · Oncogene · doi:10.1038/sj.onc.1205007 · Cited by 27
Lee, C.-H., Wooldridge, T. R., & Laimins, L. A. (2006) · Virology · doi:10.1016/j.virol.2006.08.028 · Cited by 26
Chapter 2 Cellular and Molecular Biological Aspects of Cervical Intraepithelial Neoplasia
Kisseljov, F. L., Sakharova, O., & Kondratjeva, T. T. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01202-1 · Cited by 26
Human Papillomavirus E6 and E7 Oncogenes
Münger, K., Howley, P. M., & DiMaio, D. (2007) · Springer eBooks · doi:10.1007/978-0-387-36523-7_10 · Cited by 25
Burks, E. A., Johnson, W. H., & Whitman, C. P. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9808402 · Cited by 25
New HPV E6 binding proteins: dangerous liaisons?
Kubbutat, M. H. G., & Vousden, K. H. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01267-0 · Cited by 25
Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6
Ned, R. M., Allen, S., & Pol, S. V. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4866-4870.1997 · Cited by 24
Genetic variants and signatures of selective sweep of Hanwoo population (Korean native cattle)
Lee, T., Cho, S., Seo, K.-S., Chang, J., Kim, H., & Yoon, D. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.7.211 · Cited by 23
Qiao, L., Zhang, Q., Zhang, W., & Chen, J. J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13806 · Cited by 23
Self-citationLudvigsen, M., Jacobsen, C. B., Maunsbach, A. B., & Honoré, B. (2009) · PROTEOMICS · doi:10.1002/pmic.200900321 · Cited by 22
Squarzanti, D. F., Sorrentino, R., Landini, M. M., Chiesa, A. D., Pinato, S., Rocchio, F., Mattii, M., Penengo, L., & Azzimonti, B. (2018) · Virology Journal · doi:10.1186/s12985-018-1086-4 · Cited by 22
Celestine, N., Bach, A., Engström, Å., Strømgaard, K., Lundström, P., Ferguson, N., & Jemth, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190264 · Cited by 22
Melnick, A. M., Fruchtman, S. M., Zelent, A., Liu, M., Huang, Q., Boczkowska, B., Calasanz, M. J., Fernández, A. F., Licht, J. D., & Najfeld, V. (1999) · Leukemia · doi:10.1038/sj.leu.2401513 · Cited by 22
Hamada, K., Shirakawa, T., Gotoh, A., Roth, J. A., & Follen, M. M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.035 · Cited by 22
Braun, K., Ehemann, V., Waldeck, W., Pipkorn, R., Corban-Wilhelm, H., Jenne, J., Gissmann, L., & Debus, J. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.02.022 · Cited by 22
Zhang, W., Chen, H., Chen, Y., Liu, J., Wang, X., Yu, X., Chen, J. J., & Zhao, W. (2015) · Oncotarget · doi:10.18632/oncotarget.2867 · Cited by 21
Self-citationVázquez-Ortíz, G., GARCÍA, J. A., Ciudad, C. J., Noé, V., Peñuelas, S., López-Romero, R., Mendoza‐Lorenzo, P., Piña‐Sánchez, P., & Salcedo, M. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00831.x · Cited by 21
Mavromatis, K. O., Jones, D. L., Mukherjee, R., Yee, C., Grace, M. R., & Münger, K. (1997) · Virus Research · doi:10.1016/s0168-1702(97)00090-7 · Cited by 19
Jansen‐Dürr, P. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00006-0 · Cited by 19
Mythily, D. V., Krishna, S., & Tergaonkar, V. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-7-1707 · Cited by 18
Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.
Wang, G., Wang, Q., Fan, Y., & He, X. (2017) · Europe PMC (PubMed Central) · Cited by 17
Mutational Analysis of Transcriptional Activation by the Bovine Papillomavirus Type 1 E6
Chen, J. J., Hong, Y., & Androphy, E. J. (1997) · Virology · doi:10.1006/viro.1997.8725 · Cited by 17
Self-citationFogel, S., & RIOU, G. F. (1998) · Virology · doi:10.1006/viro.1998.9086 · Cited by 17
Epigenetic Changes Accompanying Human Mammary Epithelial Cell Immortalization
Yaswen, P., & Stampfer, M. R. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011364925259 · Cited by 16
Murray, M. M., Terry, N. H. A., & Keyomarsi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1809 · Cited by 16
Li, W., Zhang, X., Gao, T., Liu, L., Zhang, C., Yang, H., Xie, J., Pan, W. D., Deng, D. Y. B., Zhang, C., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05495-3 · Cited by 15
Liu, Y., Hong, Y., Androphy, E. J., & Chen, J. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000640200 · Cited by 15
Self-citationRapp, L., Liu, Y., Hong, Y., Androphy, E. J., & Chen, J. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202373 · Cited by 15
Self-citationZn Finger Containing Proteins as Targets for the Control of Viral Infections
García, C. C., & Damonte, E. B. (2007) · Infectious Disorders - Drug Targets · doi:10.2174/187152607782110004 · Cited by 14
Proteome alteration induced by hTERT transfection of human fibroblast cells
Mazzucchelli, G., Gabelica, V., Smargiasso, N., Fléron, M., Ashimwe, W., Rosu, F., Pauw‐Gillet, M. D., Riou, J., & Pauw, E. D. (2008) · Proteome Science · doi:10.1186/1477-5956-6-12 · Cited by 14
Ristriani, T., Nominé, Y., Laurent, C., Weiss, É., & Travé, G. (2002) · Protein Expression and Purification · doi:10.1016/s1046-5928(02)00570-3 · Cited by 14
Cho, Y. M., Cho, C., Joung, O., LEE, K., Park, S. J., & Yoon, D. H. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00109-1 · Cited by 14
Searching for Antiviral Drugs for Human Papillomaviruses
Underwood, M., Shewchuk, L. M., Hassell, A. M., & Phelps, W. C. (2000) · Antiviral Therapy · doi:10.1177/135965350000500401 · Cited by 14
Xia, Y., Deng, Y., Zhou, Y., Li, D., Sun, X., Gu, L., Chen, Z., & Zhao, Q. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3526 · Cited by 13
Metadata
- Authors
- Chen, J. J., Reid, C. E., Band, V., & Androphy, E. J.
- Affiliations
- Tufts University (US)
- Venue
- Science
- Published
- 1995-07-28
- Volume
- 269
- Issue
- 5223
- Pages
- 529-531
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1986169988
- Cited by
- 275
- References
- 39
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 6
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29ca056803-02, 5r01ca044174-08)
- National Cancer Institute (R29CA56803, R01-CA44174)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- calcium-binding proteins, bovine papillomavirus type 1, human papillomavirus, protein-protein interaction, endoplasmic reticulum, cervical cancer
- MeSH terms
- Calcium-Binding Proteins, Cell Transformation, Viral, Cells, Cultured, Endoplasmic Reticulum, HeLa Cells, Humans, Oncogene Proteins, Viral, Recombinant Fusion Proteins, Repressor Proteins, Viral Proteins, Papillomaviridae, Ubiquitin-Protein Ligases, Bovine papillomavirus 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.